Your browser doesn't support javascript.
loading
Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival.
Geelen, Inge G P; Thielen, Noortje; Janssen, Jeroen J W M; Hoogendoorn, Mels; Roosma, Tanja J A; Willemsen, Sten P; Valk, Peter J M; Visser, Otto; Cornelissen, Jan J; Westerweel, Peter E.
Afiliación
  • Geelen IGP; Department of Hematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Thielen N; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Janssen JJWM; Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands.
  • Hoogendoorn M; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Roosma TJA; Department of Hematology, Medical Center Leeuwarden, Dordrecht, the Netherlands.
  • Willemsen SP; Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Valk PJM; Department of Biostatistics, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Visser O; Department of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Cornelissen JJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Westerweel PE; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Haematologica ; 102(12): e486-e489, 2017 12.
Article en En | MEDLINE | ID: mdl-28860340
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Haematologica Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Haematologica Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos